Melbourne-based startup Lyrebird Well being has just lately raised $12 million in new funding from a enterprise spherical led by 5 V Capital and United Kingdom-based Octopus Ventures, with participation from Startmate.
Launched in 2023, it affords a generative AI-powered medical documentation instrument for basic practitioners. Its AI scribe has been built-in into market-leading EMR methods in Australia, reminiscent of Finest Apply and Gentu.
WHAT IT’S FOR
In a weblog submit, Lyrebird Well being shared that it’ll utilise its contemporary funds for international enlargement, beginning in the UK.
In February, the startup introduced its first UK partnership with Alder Hey Kids’s NHS Basis Belief for a phased implementation of its AI scribe.
“With this increase, we’ll deepen our funding in product high quality, privateness, and security,” founder Kai Van Lieshout added.
MARKET SNAPSHOT
Fellow AI scribe developer, Heidi Well being, additionally primarily based in Melbourne, raked in virtually $17 million in Sequence A funding in March. The startup stated these proceeds will go to creating new capabilities of its AI scribe, reminiscent of pre-chart abstract creation. Heidi additionally labored with Telstra Well being to launch its medical documentation instrument in February.
In the meantime, Lyrebird additionally just lately secured a partnership with King’s Hospital in Dubai and introduced the mixing of its AI instrument into the pre-consultation platform of Sydney-based well being tech firm HealthShare.
In August final yr, outpatient departments throughout Gold Coast Well being in Queensland underwent the primary stage trial of Lyrebird’s AI scribe.
